-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate cost of goods produced and sold and services rendered during the reporting period.
-
Summary
-
NEUROONE MEDICAL TECHNOLOGIES Corp quarterly/annual Cost of Revenue history and growth rate from Q4 2020 to Q2 2024.
- NEUROONE MEDICAL TECHNOLOGIES Corp Cost of Revenue for the quarter ending June 30, 2024 was $544K, a 40.8% increase year-over-year.
- NEUROONE MEDICAL TECHNOLOGIES Corp Cost of Revenue for the twelve months ending June 30, 2024 was $2.79M, a 170% increase year-over-year.
- NEUROONE MEDICAL TECHNOLOGIES Corp annual Cost of Revenue for 2023 was $1.5M, a 518% increase from 2022.
- NEUROONE MEDICAL TECHNOLOGIES Corp annual Cost of Revenue for 2022 was $242K, a 12.3% decline from 2021.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Quarterly (USD)
Cost of Revenue, YoY Quarterly Growth (%)